Veterinary Auto-immune Therapeutics Market Size
Veterinary Auto-immune Therapeutics Market size was valued to be USD 3.1 billion in 2022 and is expected to reach USD 5.2 billion in 2032 with a CAGR of 5.3% from 2023 to 2032 owing to increasing threat of transfer of zoonotic diseases among human, rising incidence of auto-immune diseases in livestock animals, increasing awareness and diagnosis of autoimmune diseases, growing companion animal ownership, increasing expenditure on animal healthcare, and rising in animal health medicalizing rate.
To get key market trends
Drugs used in veterinary auto-immune therapies are those meant for animals whose immune systems malfunction and begin to attack their own organs or tissues. Among animal auto-immune illnesses are pemphigus vulgaris, autoimmune hemolytic anemia, canine systemic lupus, rheumatoid arthritis, etc. These disorders can arise from infections, tumors, or particular medicines or from no clear reason at all. Auto-immune therapies center on modulating the immunological reaction. They are meant to lower the symptoms and inflammation, therefore lowering the related discomfort, or stop the incorrect immune response.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Veterinary Autoimmune Disease Therapeutics Market Size in 2022 | USD 3.1 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 5.3% |
| 2032 Value Projection | USD 5.2 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 236 |
| Tables, Charts & Figures | 409 |
| Segments covered | Therapy Type, Disease, Animal, Distribution Channel, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
What are the growth opportunities in this market?
COVID-19 Impact
Lockdowns, social distance rules, and the prioritizing of critical services led many veterinary hospitals and clinics to temporarily close or restrict themselves during the epidemic. Veterinary hospitals allowed only severe veterinary cases to admittance during such periods. Therefore, Covid-19 significantly affects the whole veterinary medicines business including treatments for auto-immune diseases.
Problems with travel and transportation limited market growth, which finally reduced demand for veterinary auto-immune therapy. Furthermore upsetting the supply chain—including the animal health sector—was the epidemic. The loss of labour and human resources seriously affected supply and demand since it limited development.
Conversely, the COVID-19 epidemic led a notable increase in pet ownership. A lot of people yearned for company during lockdowns, which drove up pet adoption. The market for animal healthcare has benefited generally from rising pet ownership. Veterinary auto-immune disorders' rising frequency drives desire for quicker and more effective therapy and treatment solutions.
Veterinary Auto-immune Therapeutics Market Trends
Some key trends in the market includes growing awareness among pet owners and veterinarians regarding autoimmune diseases in animals, and rising demand for auto-immune therapeutics among companion animals due to the high risk of HIV transmission from an animal source to human with weakened immunity and the transmission of allergy components from companion animals to family members.
The increasing pet ownership is also a key factor driving the growth of market. According to the American Pet Products Association's (APPA) 2021-2022 National Pet Owners Survey, 70% of the U.S. households, or around 90.5 million families, own a pet and this number is expected to increase in future Increasing companion animal ownership leads to rise on animal healthcare, in turn to an increase in the medicalization rate for animals.
Veterinary Auto-immune Therapeutics Market Analysis
Learn more about the key segments shaping this market
Type of treatment determines the divide in the veterinary auto-immune treatments marketcorticosteroids, azathioprine, cyclosporine, mycophenolate, leflunomide, cyclophosphamide, levothyroxine, folic acid, hydroxychloroquine, and chloroquine. Corticosteroids had the most income among USD 1.1 billion in 2022 and expected to increase in the coming years. Corticosteroids are powerful anti-inflammatory agents. Many autoimmune diseases seen in veterinary medicine produce an excessive immune response and inflammation that destroys tissue. Corticosteroids help to reduce inflammation by weakening the reaction of the immune system, therefore minimising the severity of symptoms, and providing relief to sick animals.
Veterinary auto-immune treatments market is split based on disorders into hypothyroidism, pemphigus disease, canine lupus, auto-immune haemolytic anaemia, bullous pemphigoid, discoid lupus erythematosus, immune-related arthritis, and other diseases. With 30.7% of the market share in 2022, the segment on hypothyroidism is expected to be largest. Though it arises seldom in other animals like cats, horses, and other companion animals, hypothyroidism is most common in dogs.
Learn more about the key segments shaping this market
Veterinary auto-immune therapies market is split depending on animal type into companion animals, cattle animals, and other animals. Dogs, cats, horses, and other companion animals further split the segment on companion animals. Further divisions within the section of livestock animals are cattle, swine, poultry, sheep, and other animals. With 61.3% of the market share in 2022, the segment with companion animals is largest. The fast rising pet ownership, the great frequency of zoonotic diseases, the rising acceptance of pet insurance, and the growing requirement of diagnostics and suitable treatment are the main elements driving the expansion of this market.
Based on distribution channel, the veterinary auto-immune therapeutics market is classified into veterinary hospitals and veterinary clinics. Veterinary hospitals held the largest share of 57.7% in 2022 owing to the well-established facilities for treatment and availability of wide range of medications in hospitals. The increasing prevalence of zoonotic diseases, the growing need of diagnostics, the increasing visits to veterinary hospitals and clinics, and the increasing number of veterinary practitioners are the factors driving the market trends.
Looking for region specific data?
North America veterinary auto-immune treatments market is expected to reach USD 2.2 billion in 2032 and earned substantial income in 2022 with a CAGR of 5.5% from 2023–2032. There are many companion animals available in North America; among them are dogs, horses, and cats. Pet owners are giving their animals more thought since their bond is developing to be strong. As more individuals see their dogs as members of the family, advanced veterinary treatment becomes more sought after. Pet owners driving the need for relevant treatments in the region are searching for quick fixes for autoimmune disorders in their animals.
Veterinary Auto-immune Therapeutics Market Share
The prominent players in the veterinary auto-immune therapeutics market are
- Aratana Therapeutics inc.
- Pfizer Inc.
- Vet-Stem Inc.
- Ambrx Inc.
- Taconic Biosciences Inc.
- JBS United
- Virbac
- Eli Lily and Company
- Jaguar Animal Health Inc.
These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.
The global Veterinary Auto-immune Therapeutics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
Market Size, By Therapy Type
- Corticosteroids
- Azathioprine
- Cyclosporine
- Mycophenolate
- Leflunomide
- Cyclophosphamide
- Levothyroxine
- Folic acid
- Hydroxychloroquine
- Chloroquine
Market Size, By Disease
- Hypothyroidism
- Pemphigus disease
- Canine lupus
- Auto-immune haemolytic anaemia
- Bullous pemphigoid
- Discoid lupus erythematosus (DLE)
- Immune-related arthritis
- Other diseases
Market Size, By Animal Type
- Companion animals
- Dogs
- Cats
- Horses
- Other companion animals
- Livestock animals
- Cattle
- Swine
- Poultry
- Sheep
- Other livestock animals
- Other animals
Market Size, By Distribution Channel
- Veterinary hospitals
- Veterinary clinics
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy